Esophageal carcinoma (EC) is an aggressive and the eighth most common cancer accounting for 500,000 deaths every year. In addition, EC has a poor prognosis and an overall 5-year survival rate. Surgery is the standard treatment for EC, besides neoadjuvant chemotherapy and chemoradiotherapy with esophagectomy. The poor prognosis of EC is associated with metastatic lymph nodes. Hence, surgical outcomes in EC highly depend on lymphadenectomy and primary tumor invasion.
To learn more about the “ Lymphadenectomy in Middle Third Esophagus Carcinoma ,” join the leading Surgical Oncologist, Dr. Abhishek Jain , in our informative webinar on 24 th May 2023 , 6:00 PM IST onwards . Stay Tuned to Know More! Suggested readings Treating Pancreatic Cancers: A New Hope X-ray Dosimeter Capsule Helps Monitor Radiotherapy in Real-time Can Medical Cannabis be an Alternative to Opioids in Treating Pain?…
